Access cutting-edge neonatal respiratory failure treatment through this clinical trial at a research site in San Diego. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this San Diego location
Preparing your pre-screening questions…
Access neonatal respiratory failure specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related neonatal respiratory failure treatment provided free
Check if you qualify for this neonatal respiratory failure clinical trial in San Diego, CA
No-Cost Study Care
Local to San Diego
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Preterm neonates born at less than 30 weeks' gestation are commonly maintained on invasive or non-invasive respiratory support to facilitate gas exchange. While non-invasive respiratory support (NIS) can be gradually reduced over time as the infant grows, most weaning strategies often lead to weaning failure. This failure is evidenced by an increase in significant events such as apneas, desaturations, and/or bradycardias, increased work of breathing, or an inability to oxygenate or ventilate, resulting in escalated respiratory support. Although the optimal approach to weaning NIS remains uncertain, neonatal units that delay Continuous Positive Airway Pressure (CPAP) weaning until 32-34 weeks corrected gestational age exhibit lower rates of chronic lung disease. Therefore, the investigators aim to compare the duration on respiratory support and oxygen exposure in infants born at less than 30 weeks' gestational age who undergo a structured weaning protocol that includes remaining on CPAP until at least 32-34 weeks corrected gestational age (CGA). The hypothesis posits that preterm infants following a structured weaning protocol, including maintaining CPAP until a specific gestational age, will demonstrate lower rates of weaning failure off CPAP (defined as requiring more support and/or experiencing increased stimulation events 72 hours after CPAP weaning) than those managed according to the medical team's discretion.
Sponsor: University of California, San Diego
Yes, this clinical trial (NCT06123143) has an active research site in San Diego, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for neonatal respiratory failure treatment options in San Diego, CA, this clinical trial (NCT06123143) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Diego research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neonatal respiratory failure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all neonatal respiratory failure clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in San Diego — not just this study.
Browse Rheumatoid Arthritis Trials in San Diego →